![Mechanism of action of rituximab. Rituximab is a monoclonal antibody... | Download Scientific Diagram Mechanism of action of rituximab. Rituximab is a monoclonal antibody... | Download Scientific Diagram](https://www.researchgate.net/publication/221924296/figure/fig3/AS:667588631744528@1536176941819/Mechanism-of-action-of-rituximab-Rituximab-is-a-monoclonal-antibody-directed-against.png)
Mechanism of action of rituximab. Rituximab is a monoclonal antibody... | Download Scientific Diagram
![Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fncprheum0424/MediaObjects/41584_2007_Article_BFncprheum0424_Fig1_HTML.jpg)
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
![Anti‐CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis - Korhonen - 2010 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library Anti‐CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis - Korhonen - 2010 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/bb3b76c5-4126-4951-ab23-1ae03c4a6d0f/bcpt_452_f1.gif)
Anti‐CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis - Korhonen - 2010 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
![Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience | SpringerLink Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-017-0612-x/MediaObjects/12325_2017_612_Fig1_HTML.gif)
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience | SpringerLink
The Risk of Hyperglycaemia with the use of Rituximab in Rheumatoid Arthritis. Results from a Meta-analysis of Randomised Clinica
![Immunosuppressive therapy with rituximab in common variable immunodeficiency | Clinical and Molecular Allergy | Full Text Immunosuppressive therapy with rituximab in common variable immunodeficiency | Clinical and Molecular Allergy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12948-019-0113-3/MediaObjects/12948_2019_113_Fig1_HTML.png)